GMP BIO CO., LTD.

닫기

PIPELINE

Overview
Classification PIPELINE Candidate material Preclinical Clinical New Drug approval Item permit
1 2 3
Cell therapy
(*Treg cell)
Alzhimer's
disease
(VT301)
  • Technology transfer completed (Kyung Hee university)
Natural
product medicine
(VT012)
  • Clinical 2 phase completed (Hanlim pharmaceutical)
  • Clinical 3 phase IND
*COPD
(VT014)
Bronchitis
  • Clinical 2 phase completed (Hanlim pharmaceutical)
  • Clinical 3 phase in progress
*COPD
  • Clinical 2 phase cost $12 billion
  • Clinical 3 phase an estimate of 200 billion won in costs
Depression (VT011)
  • Clinical 2 phase completed (Korea's Ministry of Food and Drug Safety (MFDS))
  • Clinical 3 phase IND
Alopecia / Depilation
(VT015)
  • Complete preclinical proof of efficacy, clinical trial planning, transfer of technology (Ewha women university)
Natural product
functional material
(Health functional food)
Regulation of
blood glucose (VT021)
  • Individual recognition type item permit (2010-33)

*COPD: chronic obstructive pulmonary disease*Treg: immune-regulatory T cell

top